Insider Trading History of Lerner Neil

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Lerner Neil since 2011. This trader's CIK number is 1505148. At the time of last reporting, Lerner Neil was the CHIEF ACCOUNTING OFFICER of Compass Therapeutics, Inc.. (stock ticker symbol CMPX). Also see all insider trading activities at Compass Therapeutics, Inc..

Note that in the past Lerner Neil also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Compass Therapeutics, Inc. (CMPX) by Lerner Neil

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 CMPX 20,000 $28,400 0 $0 0 $0

Yearly summary of insider trading at Psychemedics Corp (PMD) by Lerner Neil

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 PMD 0 $0 9,057 $136,779 0 $0
2018 PMD 0 $0 4,892 $98,242 0 $0
2016 PMD 0 $0 3,000 $74,250 0 $0
2015 PMD 3,000 $30,960 0 $0 0 $0
2012 PMD 2,500 $24,500 0 $0 0 $0
2011 PMD 7,895 $77,190 0 $0 0 $0


Insider trading activities at 2 companies by Lerner Neil:

1. Compass Therapeutics, Inc. (CMPX)

2. Psychemedics Corp (PMD)

Table 1. Insider trading of Compass Therapeutics, Inc. (CMPX) by Lerner Neil

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-04-07 CMPX Buy 20,000 1.42 28,400

Table 2. Insider trading of Psychemedics Corp (PMD) by Lerner Neil

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-03-12 PMD Sale 1,412 15.06 21,264
2019-03-11 PMD Sale 7,645 15.11 115,515
2018-05-21 PMD Sale 3,013 20.14 60,681
2018-05-22 PMD Sale 1,879 19.99 37,561
2016-11-18 PMD Sale 3,000 24.75 74,250
2015-09-10 PMD Buy 3,000 10.32 30,960
2012-06-15 PMD Buy 2,500 9.80 24,500
2011-05-25 PMD Buy 5,895 10.01 59,008
2011-03-17 PMD Buy 2,000 9.09 18,182

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lerner Neil (CHIEF ACCOUNTING OFFICER of Compass Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.